Thyrocare Technologies Limited (BOM:539871)
India · Delayed Price · Currency is INR 403.30
+1.70 (0.42%)
At close: Feb 13, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 64.19 billion as of February 13, 2026. Its market cap has increased by 53.52% in one year.
Market Cap
64.19B
Enterprise Value
62.51B
Revenue
7.92B
Ranking
n/a
PE Ratio
46.08
Stock Price
403.30
Market Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 64.19B, an increase of 93.34%. That is a compound annual growth rate of 6.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 64.19B | -9.57% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| May 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 14.66B |
| Chandan Healthcare | 6.96B |
| Star Imaging and Path Lab | 1.27B |
| Modern Diagnostic & Research Centre | 1.16B |
| Invicta Diagnostic | 829.75M |
| Aspira Pathlab & Diagnostics | 631.17M |
| Nidan Laboratories and Healthcare | 236.30M |
| Family Care Hospitals | 188.51M |